Where are you getting it from?
Sent from my iPhone
On Jun 20, 2018, at 2:36 PM, Byron Wood
<bwood@xxxxxxxxxxxxxxxxx<mailto:bwood@xxxxxxxxxxxxxxxxx>> wrote:
Be prepared for sticker shock- over $800 for a box of 12.
From: optimal-bounce@xxxxxxxxxxxxx<mailto:optimal-bounce@xxxxxxxxxxxxx>
[mailto:optimal-bounce@xxxxxxxxxxxxx] On Behalf Of Paul Paquette
Sent: Tuesday, June 19, 2018 9:03 AM
To: optimal@xxxxxxxxxxxxx<mailto:optimal@xxxxxxxxxxxxx>
Subject: [optimal] Re: Get it while you can, another Fluorescein shortage
I haven't had to order in a while. I thought Akorn was the only game in town.
When did Novartis get in the game? Or should I say when did Alcon return to the
game since they were aquired by Novartis about 10 yrs ago?
Paul Paquette
-----Original Message-----
From: Amy Goldstein
<amydesireephoto@xxxxxxxxx<mailto:amydesireephoto@xxxxxxxxx>>
To: optimal <optimal@xxxxxxxxxxxxx<mailto:optimal@xxxxxxxxxxxxx>>
Sent: Mon, Jun 18, 2018 10:45 pm
Subject: [optimal] Re: Get it while you can, another Fluorescein shortage
Thanks for the heads up!
Amy Désirée Goldstein, CRA, OCT-C
Education Chair OPS Denver Mid Year Meeting 2018
Ophthalmic Photographer
Byers Eye Institute
Stanford Health Care
2452 Watson Court
Palo Alto, CA 94303
(650)723-6995
amydesireephoto@xxxxxxxxx
<mailto:agoldstein@xxxxxxxxxxxxxxxxxxxxxx>
On Mon, Jun 18, 2018 at 9:19 AM, Johnathan Hawkins
<jhawk27@xxxxxxxxxx<mailto:jhawk27@xxxxxxxxxx>> wrote:
Thank you sir!
Johnathan Hawkins COT, CRA, OCT-C
Southwest Retina Specialists
On Jun 18, 2018, at 10:45 AM, Steffens, Tim
<tjsteffe@xxxxxxxxxxxxx<mailto:tjsteffe@xxxxxxxxxxxxx>> wrote:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?utm_campaign=06-15-2018%20Drug%20Shortages&utm_medium=email&utm_source=Eloqua&AI=Fluorescein+Injection&st=c&tab=tabs-4&panels=0&elqTrackId=19fc945273254cf5b35d18ea0f179346&elq=1a87050908e04e3fbdfce0c1805e9e28&elqaid=3949&elqat=1&elqCampaignId=3075<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.accessdata.fda.gov_scripts_drugshortages_dsp-5FActiveIngredientDetails.cfm-3Futm-5Fcampaign-3D06-2D15-2D2018-2520Drug-2520Shortages-26utm-5Fmedium-3Demail-26utm-5Fsource-3DEloqua-26AI-3DFluorescein-2BInjection-26st-3Dc-26tab-3Dtabs-2D4-26panels-3D0-26elqTrackId-3D19fc945273254cf5b35d18ea0f179346-26elq-3D1a87050908e04e3fbdfce0c1805e9e28-26elqaid-3D3949-26elqat-3D1-26elqCampaignId-3D3075&d=DwMGaQ&c=imBPVzF25OnBgGmVOlcsiEgHoG1i6YHLR0Sj_gZ4adc&r=fxTqv4dcm3oxOW4EB1VzCwzwARIN9aocysnup_tupaQ&m=Sgx0Ss9H230Bmn1SPXZXUl6Dlo9c-CsYfadcgGM_QL8&s=LO6sJfMOi3qH87hfgz6H5q5Ep89KQ3Gl_3i5mZAnkhQ&e=>
Thanks,
Tim
**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be
used for urgent or sensitive issues
---------------------------------------------------------------------
This e-mail message, including any attachments, is intended only for the use of
the individual(s) to whom it is addressed, and may contain information that is
privileged, confidential, and prohibited from disclosure under applicable law.
If you are not the intended recipient, please delete/destroy all electronic and
hard copies of this e-mail immediately and notify the sender that the e-mail
was sent in error. Thank you.
